ADCT
ADC Therapeutics SAData: 2026-09-04
Quick Stats
Sep 04, 202627.8
AI Score
EXTENDED0.99
Volume Ratio
TBA
Next Earnings
16
+ve Days (30d)
10
-ve Days (30d)
ADCT Price vs Max Options Open Interest
How to read this: the line is the stock price; the bars show where the most option open interest sits each day. Strikes with heavy open interest often act as magnets or barriers for price ("max pain" zones). Scroll right for the most recent days.
ADCT Max Change In Options Open Interest
How to read this: each bar is the option contract whose open interest changed the most yesterday. Green bars = new positions being opened (conviction building at that strike); red bars = positions being closed. Call builds above the current price suggest upside bets; put builds below it suggest hedging or downside bets.
ADCT Options - Sort by Max open Interest (near term)
6th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ADCT Daily Out of Money Options - Sort by Max open Interest (near term)
6th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ADCT Daily In the Money Options - Sort by Max open Interest (near term)
6th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ADCT Most Active Options by Volume(near term)
6th September 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ADCT Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Volume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ADCT Stock Summary
Last updated Sep 04, 2026
ADCT is currently trading at $1.36, positioned below its 200-day moving average of $2.96, suggesting bearish momentum. The stock has a 52-week range of $0.7796 to $4.98.
Technical Analysis: The 50-day moving average stands at $1.16, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 63.173, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.186, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates ADCT at 27.8/100 with a EXTENDED recommendation.
ADCT (ADC Therapeutics SA) Indicators
Last updated Sep 04, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 63.173 |
| CMF (20) | 0.186 |
| ROC (10) | 36.464 |
| ADX (14) | 26.404 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.035 |
| AROONOSC (14) | 78.571 |
| WILLAMS %R (14) | -2.379 |
| MFI (14) | 78.823 |
ADC Therapeutics SA is above the 50 Day SMA but below the 200 Day SMA — short-term strength within a longer-term downtrend (Mixed).
ADCT Moving Averages Analysis
ADC Therapeutics SA has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Sep 04, 2026
ADCT (ADC Therapeutics SA) Simple Moving Averages
Moving Averages are last updated Sep 04, 2026
| Days | MA |
|---|---|
| 10 | 1.17 |
| 20 | 1.12 |
| 30 | 1.11 |
| 50 | 1.16 |
| 100 | 2.02 |
| 200 | 2.96 |
ADCT Fundamental Analysis
| P/E (Forward) | -- |
| P/E (Trailing) | -- |
| Market Cap ($) | 168.5 million |
| Earnings/Share ($) | -0.58 |
| Net Profit Margin (%) | -1.2177 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.76 |
| EPS Estimate Next Year ($) | -0.6775 |
| WallStreet Target Price ($) | 3.33 |
| Most Recent Quarter |
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).